Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/26/09
Cagatay T et al. – Diagnostic accuracy of TST for detecting latent tuberculosis is high among patients with inflammatory diseases even in the setting of immunosuppression. The risk of development of active TB is increased in this group of patients despite chemoprophylaxis, but this risk remains within the acceptable limits even in a moderate-tuberculosis incidence country, if proper chemoprophylaxis regimen is adhered.
Methods- 702 patients with different inflammatory diseases receiving TNF-&alpha antagonists followed up from August 2005 to July 2008 at our department of chest disease
- All patients had tuberculin skin test (TST) and postero-anterior chest radiograph (CXR) prior to anti TNF-&alpha antagonist treatment
- All patients with TST result ≥ 5 mm or fibrotic lesions on CXR were administered chemoprophylaxis with isoniazid (INH) for 9 months
- 6 patients developed active tuberculosis (4 pulmonary and 2 extrapulmonary) during follow-up period
- TST found positive in 434 (61.8%) of patients
- Patients, who were already on immunosuppressive therapy and who were not, were compared for difference in their TST results and no statistically significant difference was found
- Chemoprophylaxis administered overall to 583 (83.0%) patients among which 31 (5.3%) developed hepatotoxicity
- Of patients who developed active tuberculosis, all were decided to receive INH chemoprophylaxis
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Effect of biomagnetic therapy versus physiotherapy for treatment of knee osteoarthritis: A randomized controlled trial
Journal of Rehabilitation Medicine, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


